4-(4-Chloro-benzyloxy)-piperidine hydrochloride, 95.0%, 100mg

3-Methoxysalicylic acid, min. 97%, for synthesis, 5 g, glass packaging

2,3-Difluoro-N,N-dimethylbenzamide, 95%, 500mg

Boc-D-Lys-OH, 98%, 25g

Methyl 2-Methoxyphenylacetate>98.0%(GC)5g

2-Fluoro-3,5-dimethylpyridine, 95+%, 5g

3-Chloro-2-(trifluoromethyl)aniline, 98.0%, 10g

L-Tyrosine allyl ester 4-toluenesulfonate salt, 99.0%, 1g

1H-Benzo[d]imidazole, 97.0%, 1kg

Ethyl 2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzo[d]imidazole-5-carboxylate hydrochloride (Dabigatran Impurity), 97%, 50mg

1-BENZENESULFONYL-5-BROMO-1H-PYRROLO[2,3-B]PYRIDINE, 95.0%, 250mg

7-Methyl-3,4-dihydroisoquinolin-1(2H)-one, 95.0%, 250mg

1-(5-Cyano-2-pyridinyl)-4-piperidinecarboxylic acid, 2.5g